Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Project X** was Professional Disposables International's internal investigational designation for preoperative skin-antisepsis test materials supplied in 5.1 mL, 10.5 mL, and 26 mL formats. The registered protocols identify the active formulation as chlorhexidine gluconate 3.15% w/v plus isopropyl alcohol 70% v/v, evaluated against a Prevantics Maxi Swabstick active control under ASTM E1173 methods. The available public records establish Project X as an investigational topical antiseptic product but do not establish a marketed trade name or INN for the exact Project X product. ([cdn.clinicaltrials.gov](https://cdn.clinicaltrials.gov/large-docs/80/NCT03861780/Prot_SAP_000.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Project X.